12-51246760-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001031628.2(SMAGP):āc.106C>Gā(p.Leu36Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000017 in 1,586,346 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001031628.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SMAGP | NM_001031628.2 | c.106C>G | p.Leu36Val | missense_variant | 3/4 | ENST00000603798.6 | |
SMAGP | NM_001033873.1 | c.106C>G | p.Leu36Val | missense_variant | 3/4 | ||
DAZAP2 | NM_001136269.2 | downstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SMAGP | ENST00000603798.6 | c.106C>G | p.Leu36Val | missense_variant | 3/4 | 1 | NM_001031628.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152114Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000185 AC: 4AN: 216520Hom.: 0 AF XY: 0.0000171 AC XY: 2AN XY: 117172
GnomAD4 exome AF: 0.0000167 AC: 24AN: 1434232Hom.: 0 Cov.: 30 AF XY: 0.0000169 AC XY: 12AN XY: 711828
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152114Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74282
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2021 | The c.106C>G (p.L36V) alteration is located in exon 3 (coding exon 2) of the SMAGP gene. This alteration results from a C to G substitution at nucleotide position 106, causing the leucine (L) at amino acid position 36 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at